Skip to content
Search AI Powered

Latest Stories

NHS England elective care waiting list hits 7.6 million amid election campaigns

NHS England elective care waiting list hits 7.6 million amid election campaigns
NHS waiting list reduction efforts show limited impact despite government pledges

The elective care waiting list for NHS England has soared to a staggering 7.6 million, marking a critical juncture as the health service struggles to meet standards since February 2016 and ambulance and A&E waiting times have not been met since 2020/21 and 2015 respectively.

The revelation, detailed in a new report by the Health Foundation, underscores the immense pressure on the NHS and positions healthcare as a pivotal issue in the upcoming general election.


According to the report, the waiting list crisis has become a central point of contention between the major political parties.

Both the Conservatives and Labour have pledged to tackle the growing backlog, which includes waiting times for both elective and emergency care.

Prime Minister Rishi Sunak had vowed to reduce NHS waiting lists in January 2023, but despite a slight decrease from the peak of 7.8 million in September 2023, the numbers remain alarmingly high.

"While the government has blamed the relative lack of progress on industrial action", an analysis by the Health Foundation suggests it "accounts for less than 3 per cent of the overall waiting list and is only responsible for half of the growth in the waiting list between March and October 2023."

The findings of the analysis attribute the crisis to multiple factors beyond industrial action by NHS staff.

They point to chronic issues such as hospital capacity constraints, delayed patient discharges and increased lengths of hospital stays, underinvestment, and systemic inefficiencies as factors for the rise in wait times for the patients.

The report also highlights that these problems are more pronounced in deprived areas, where patients face even longer waits for treatment.

Over 302,000 patients have been waiting more than a year for treatment with an average waiting time of 13.9 weeks as of April 2024.

Moreover, disparities in waiting times are stark, with patients waiting time in Brighton and Hove is 21.6 weeks, while in South Tyneside it is 9.2 weeks.

In May 2024, England's urgent and emergency care services reported average response times of 8 minutes 16 seconds for life-threatening Category 1 ambulance calls and 32 minutes 44 seconds for urgent Category 2 calls.

A&E performance stood at 72.1 per cent of patients treated within 4 hours, with 439,411 patients enduring over 12-hour waits due to system pressures.

Call for reform 

The report also noted that public dissatisfaction with the NHS is at an unprecedented high, adding to the urgency for political leaders to propose effective solutions.

As the election approaches, the next government faces an unprecedented task of revitalizing the country's health service, which has been strained to its limits by ongoing crises worsened by the pandemic.

The report calls for a comprehensive reform in critical areas such as prolonged ambulance response times, overwhelmed A&E departments, and extensive patient waiting periods highlight the urgent need for comprehensive reform.

Proposed solutions emphasise optimising existing healthcare capacity, fostering innovation, and ensuring sustained long-term investment.

With public expectations soaring, proactive measures in health promotion and disease prevention emerge as vital components of a sustainable reform agenda.

More For You

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Prakash Patel was speaking at a panel discussion at the Sigma Conference

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Pharmacists need to be a part of integrated care boards (ICB) to stop GPs from monopolising services based on their needs rather than the needs of the patient, according to Prakash Patel, Community Pharmacy Engaland (CPE) representative for North London.

“The evolution of the NHS should mean there can be no decision of pharmacy without pharmacist,” Patel told delegates at the Sigma Pharmacy Conference in Baku, Azerbaijan on Tuesday.

Keep ReadingShow less
New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less